1987
DOI: 10.1097/00003246-198702000-00011
|View full text |Cite
|
Sign up to set email alerts
|

A reappraisal of norepinephrine therapy in human septic shock

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
52
1
8

Year Published

1991
1991
2016
2016

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 237 publications
(61 citation statements)
references
References 0 publications
0
52
1
8
Order By: Relevance
“…Several observational studies show that noradrenaline is the vasoconstrictive agent of choice, which combines the best compromise in term of cost, safety and ease of use [111][112][113][114][115][116][117]. There is no controlled study concerning this specific point.…”
Section: (Grade 2+) Strong Agreementmentioning
confidence: 99%
“…Several observational studies show that noradrenaline is the vasoconstrictive agent of choice, which combines the best compromise in term of cost, safety and ease of use [111][112][113][114][115][116][117]. There is no controlled study concerning this specific point.…”
Section: (Grade 2+) Strong Agreementmentioning
confidence: 99%
“…In patients with IAH and septic shock, use of norepinephrine (NE) probably has an appropriate effect on maintaining renal perfusion. NE has been reported to increase renal blood flow, urine output and creatinine clearance in experimental and human sepsis through a combined increase of renal perfusion pressure and an increase in renal vascular conductance [95][96][97][98] . Norepinehrine is more potent than dopamine at doses ranging from 0.01-3.3 µg/kg/min to achieve increase of MAP in hypotensive patients after fluid resuscitation 98,99 .…”
Section: Renal Function Supportive Measuresmentioning
confidence: 99%
“…When fluid administration fails to restore an adequate perfusion pressure, and patients do not respond to dopamine or dobutamine, NE is used with the assumption that restoration of 'physiological' blood pressure will improve organ perfusion. Relevant clinical studies are summarized in table 2 [56][57][58][59][60][61][62][63][64][65]. Most of these studies are uncontrolled, many of them even retrospective, and concern a limited number of patients.…”
Section: Clinical Studiesmentioning
confidence: 99%